...venture partner. He was SVP and head of operations and R&D at Genmab A/S (NASDAQ:GMAB; CSE:GMAB).Theratechnologies Inc. (TSX:TH...
...cancer therapies, hires a successor. Danielle Golovin Eli Lilly and Co. Trillium Therapeutics Inc. Codagenix Inc. VectivBio AG Deep Genomics Inc. Novo Ventures Theratechnologies Inc....

...end of the month. RoosterBio manufactures human mesenchymal stem cells. Theratechnologies files for NASDAQ listing Theratechnologies Inc....
...assesses cell samples to detect DNA sequences, location and orientation. BioCentury Staff Albuvirtide Frontier Biotechnologies Co. Ltd. KromaTiD Inc. RoosterBio Inc. Theratechnologies Inc. Portola...

...in 2H20. The latter two trials are in T cell lymphoma. Theratechnologies regains Egrifta rights Theratechnologies Inc....

...Next Act" ). Other new therapies backed by CHMP include anti-CD4 mAb Trogarzo ibalizumab-uiyk from Theratechnologies Inc....
...LOXO-101) Acorda Therapeutics Inc. Alexion Pharmaceuticals Inc. Amgen Inc. Bayer AG GW Pharmaceuticals plc Johnson & Johnson Merck & Co. Inc. PTC Therapeutics Inc. Roche Servier Theratechnologies Inc. UCB...

...years in the role. Hogan will remain as a consultant until April 2019. HIV company Theratechnologies Inc....

...to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy Theratechnologies Inc....

...heavily treatment-experienced patients with HIV-1 whose infections cannot be treated successfully with existing multidrug-resistant therapies. Theratechnologies Inc....
...Roche (SIX:ROG; OTCQX:RHHBY). Genentech Inc., South San Francisco, Calif. TaiMed Biologics Inc. (TPEx:4147), Taipei, Taiwan Theratechnologies Inc....
...Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Trogarzo ibalizumab-uiyk Business: Infectious Paul Bonanos ibalizumab (TMB-355, tnx-355, Hu5A8) TaiMed Biologics Inc. Theratechnologies Inc. WuXi...

...Inc. (TPEx:4147), which submitted Trogarzo's NDA to FDA, rose NT$21 (10%) to NT$234 on Wednesday. Theratechnologies Inc....
...heavily treatment-experienced patients with HIV-1 whose infections cannot be treated successfully with existing multidrug-resistant therapies. Theratechnologies...
...and has Fast Track, breakthrough therapy and Orphan Drug status to treat HIV. Paul Bonanos ibalizumab TaiMed Biologics Inc. Theratechnologies Inc. WuXi...

...heavily treatment-experienced patients with HIV-1 whose infections cannot be treated successfully with existing multidrug-resistant therapies. Theratechnologies Inc....
...distribute the drug from TaiMed Biologics Inc. (TPEx:4147), gained C$2 (28%) to C$9.23 on Tuesday. Theratechnologies...
...approval during market hours in Toronto and after market close in Taipei. Paul Bonanos ibalizumab Genentech Inc. Roche TaiMed Biologics Inc. Theratechnologies Inc. CD4...